B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Apolipoprotein E3

245 PubMed studies analyzed · 2 RCTs · Evidence Score: 43.6

Research Domains

Apolipoprotein E3 has been studied across 18 research domains including 🔥 Metabolic, 🧠 Neuroprotection, ❤️ Cardiovascular, 🔬 Oncology, 🫁 Liver & Detox. The primary research focus is 🔥 Metabolic with 27% of studies addressing this area.

Loading evidence profile...

This evidence profile for Apolipoprotein E3 is generated deterministically from 245 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.